Identification of Equine Arteritis Virus Immunodominant Epitopes Using a Peptide Microarray

Using the commercially available PEPperCHIP® microarray platform, a peptide microarray was developed to identify immunodominant epitopes for the detection of antibodies against Equine arteritis virus (EAV). For this purpose, the whole EAV Bucyrus sequence was used to design a total of 1250 peptides that were synthesized and spotted onto a microarray slide. A panel of 28 serum samples representing a selection of EAV strains was tested using the microarray. Of the 1250 peptides, 97 peptides (7.76%) showed reactivity with the EAV-positive samples. No single peptide was detected by all the positive serum samples. Seven peptides repeatedly showed reactivity above the cut-off and were considered to have diagnostic potential. Five of these peptides were within the immunodominant GP5 protein and two were within the replicase polyprotein regions NSP2 and NSP10, located in ORF1. The diagnostic sensitivity of the seven peptides selected was low, ranging from 5% to 55%; however, the combined diagnostic sensitivity and specificity of the seven peptides was 90% and 100%, respectively. This data demonstrate that multiple peptide sequences would be required to design a comprehensive serological test to cover the diversity of the EAV strains and the individual immune responses of horses.

[1]  F. C. Leung,et al.  ICTV Virus Taxonomy Profile: Arteriviridae 2021 , 2021, The Journal of general virology.

[2]  D. Westcott,et al.  Re-emergence of a genetic outlier strain of equine arteritis virus: Impact on phylogeny , 2014, Virus Research.

[3]  Louise Taylor,et al.  OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals , 2014 .

[4]  D. Burke,et al.  Antigenic and Genetic Evolution of Equine Influenza A (H3N8) Virus from 1968 to 2007 , 2011, Journal of Virology.

[5]  P. Wakeley,et al.  Development and evaluation of a Luminex multiplex serology assay to detect antibodies to bovine herpes virus 1, parainfluenza 3 virus, bovine viral diarrhoea virus, and bovine respiratory syncytial virus, with comparison to existing ELISA detection methods. , 2011, Journal of immunological methods.

[6]  W. Qi,et al.  Serodiagnosis of Echinococcus spp. Infection: Explorative Selection of Diagnostic Antigens by Peptide Microarray , 2010, PLoS neglected tropical diseases.

[7]  F. Bischoff,et al.  Combinatorial Peptide Synthesis on a Microchip , 2009, Current protocols in protein science.

[8]  A. Poustka,et al.  Combinatorial synthesis of peptide arrays with a laser printer. , 2008, Angewandte Chemie.

[9]  U. Balasuriya,et al.  Equine viral arteritis: current status and prevention. , 2008, Theriogenology.

[10]  U. Balasuriya,et al.  The immune response to equine arteritis virus: potential lessons for other arteriviruses. , 2004, Veterinary immunology and immunopathology.

[11]  R. Geraghty,et al.  Evidence that use of an inactivated equine herpesvirus vaccine induces serum cytotoxicity affecting the equine arteritis virus neutralisation test. , 2004, Vaccine.

[12]  R. Rowland,et al.  The primary neutralization epitope of porcine respiratory and reproductive syndrome virus strain VR-2332 is located in the middle of the GP5 ectodomain , 2002, Archives of Virology.

[13]  M. Ostrowski,et al.  Identification of Neutralizing and Nonneutralizing Epitopes in the Porcine Reproductive and Respiratory Syndrome Virus GP5 Ectodomain , 2002, Journal of Virology.

[14]  M.H.V. Van Regenmortel,et al.  Antigenicity and immunogenicity of synthetic peptides. , 2001 .

[15]  M. V. Van Regenmortel,et al.  Antigenicity and immunogenicity of synthetic peptides. , 2001, Biologicals : journal of the International Association of Biological Standardization.

[16]  L. Jordan,et al.  Detection of antibodies to equine arteritis virus by a monoclonal antibody-based blocking ELISA. , 2000, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.

[17]  C. Gagnon,et al.  Current knowledge on the structural proteins of porcine reproductive and respiratory syndrome (PRRS) virus: comparison of the North American and European isolates , 2000, Archives of Virology.

[18]  J. Hedges,et al.  Detection of antibodies to equine arteritis virus by enzyme linked immunosorbant assays utilizing G(L), M and N proteins expressed from recombinant baculoviruses. , 1998, Journal of virological methods.

[19]  J. Hedges,et al.  Serologic Response of Horses to the Structural Proteins of Equine Arteritis Virus , 1998, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

[20]  T. Kondo,et al.  Identification of the Major Epitope in the G_L Protein of Equine Arteritis Virus (EAV) Recognized by Antibody in EAV-infected Horses Using Synthetic Peptides , 1998 .

[21]  J. Patton,et al.  Neutralization determinants of laboratory strains and field isolates of equine arteritis virus: identification of four neutralization sites in the amino-terminal ectodomain of the G(L) envelope glycoprotein. , 1997, Virology.

[22]  M. Nowak.  Immune Responses against Multiple Epitopes: a Theory for Immunodominance and Antigenic Variation Competition between Ctl Epitopes: the Competitive Exclusion Principle , 2022 .

[23]  A. D. de Vries,et al.  Development and evaluation of an ELISA using recombinant fusion protein to detect the presence of host antibody to equine arteritis virus , 1995, Journal of Virological Methods.

[24]  P. Rottier,et al.  Identification of a neutralization site in the major envelope glycoprotein (GL) of equine arteritis virus. , 1995, Virology.

[25]  M. Raamsman,et al.  Monoclonal antibodies to equine arteritis virus proteins identify the GL protein as a target for virus neutralization. , 1994, The Journal of general virology.

[26]  G. R. Holyoak,et al.  Relationship between onset of puberty and establishment of persistent infection with equine arteritis virus in the experimentally infected colt , 1993, Journal of Comparative Pathology.

[27]  R. F. Cook,et al.  The effects of vaccination with tissue culture-derived viral vaccines on detection of antibodies to equine arteritis virus by enzyme-linked immunosorbent assay (ELISA). , 1989, Veterinary microbiology.

[28]  P. Timoney,et al.  Demonstration of the carrier state in naturally acquired equine arteritis virus infection in the stallion. , 1986, Research in veterinary science.

[29]  J. Bryans,et al.  Isolation of a filterable agent causing arteritis of horses and abortion by mares; its differentiation from the equine abortion (influenza) virus. , 1957, The Cornell veterinarian.